Figure 13.
Ability of different t.o. doses of the two enantiomers of a potent and selective 5-HT2A receptor agonist (DOI) to lower and control IOP in conscious OHT cynomolgus eyes. Reproduced with permission from ref (7). Copyright 2018 Mary Ann Liebert Publishing Inc.
